{"id":160924,"date":"2026-07-21T10:58:47","date_gmt":"2026-07-21T05:28:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=160924"},"modified":"2026-07-21T10:58:49","modified_gmt":"2026-07-21T05:28:49","slug":"venus-remedies-share-price-gains-q1-results-21-july-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/","title":{"rendered":"Venus Remedies Share Price Gains Nearly 5% After Q1 FY27 Consolidated Profit Surges 139% to Rs 22.97 Crore"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Venus Remedies share price up 4.99% at Rs 1,778.50. Q1 FY27 consolidated PAT Rs 22.97 crore, up 139.27% YoY. Revenue Rs 178.86 crore, up 30.38% YoY.<\/em><\/p>\n<p>The Venus Remedies share price gained nearly 5 percent on 21 July 2026 after the pharmaceutical company reported a striking Q1 FY27, with consolidated net profit surging 139.27 percent year on year to Rs 22.97 crore on the back of 30.38 percent revenue growth to Rs 178.86 crore, driven by expansion across its manufacturing and export operations.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#About_Venus_Remedies\" title=\"About Venus Remedies\">About Venus Remedies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Venus_Remedies_Q1_FY27_Results_Key_Numbers\" title=\"Venus Remedies Q1 FY27 Results: Key Numbers\">Venus Remedies Q1 FY27 Results: Key Numbers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Why_Venus_Remedies_Share_Price_Is_Reacting\" title=\"Why Venus Remedies Share Price Is Reacting\">Why Venus Remedies Share Price Is Reacting<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Outlook_for_Venus_Remedies_Share_Price\" title=\"Outlook for Venus Remedies Share Price\">Outlook for Venus Remedies Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#FAQs_on_Venus_Remedies_Q1_FY27_Results\" title=\"FAQs on Venus Remedies Q1 FY27 Results\">FAQs on Venus Remedies Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Why_did_Venus_Remedies_share_price_rise_on_21_July_2026\" title=\"Why did Venus Remedies share price rise on 21 July 2026?\">Why did Venus Remedies share price rise on 21 July 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#What_was_Venus_Remediess_revenue_growth_in_Q1_FY27\" title=\"What was Venus Remedies&#8217;s revenue growth in Q1 FY27?\">What was Venus Remedies&#8217;s revenue growth in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#What_products_does_Venus_Remedies_focus_on\" title=\"What products does Venus Remedies focus on?\">What products does Venus Remedies focus on?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Why_did_profit_grow_faster_than_revenue_in_Q1_FY27\" title=\"Why did profit grow faster than revenue in Q1 FY27?\">Why did profit grow faster than revenue in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Is_Venus_Remedies_profit_growth_sustainable_quarter_to_quarter\" title=\"Is Venus Remedies&#8217; profit growth sustainable quarter to quarter?\">Is Venus Remedies&#8217; profit growth sustainable quarter to quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Is_Venus_Remedies_share_price_a_buy_after_the_Q1_results\" title=\"Is Venus Remedies share price a buy after the Q1 results?\">Is Venus Remedies share price a buy after the Q1 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/venus-remedies-share-price-gains-q1-results-21-july-2026\/#Where_can_I_track_Venus_Remedies_share_price_live\" title=\"Where can I track Venus Remedies share price live?\">Where can I track Venus Remedies share price live?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Venus_Remedies\"><\/span><strong>About Venus Remedies<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/stocks\/venusrem\/venus-remedies-ltd-share-price-today\">Venus Remedies<\/a> is a pharmaceutical company focused on injectable formulations, oncology, and critical care products, with a significant presence in both the Indian domestic market and international export markets across multiple continents.<\/p>\n<p>The company has been investing in expanding its manufacturing capacity and research capabilities, particularly in complex injectable and specialty formulations that carry higher margins than standard generic products.<\/p>\n<p>Export markets have become an increasingly important growth driver for Venus Remedies, with the company&#8217;s regulatory approvals across multiple geographies supporting the kind of broad based revenue growth reflected in this quarter&#8217;s Venus Remedies share price reaction.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Venus_Remedies_Q1_FY27_Results_Key_Numbers\"><\/span><strong>Venus Remedies Q1 FY27 Results: Key Numbers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Q1 FY27<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Consolidated Net Profit<\/td>\n<td>Rs 22.97 crore<\/td>\n<td>Up 139.27% YoY from Rs 9.60 crore<\/td>\n<\/tr>\n<tr>\n<td>Revenue from Operations<\/td>\n<td>Rs 178.86 crore<\/td>\n<td>Up 30.38% YoY from Rs 137.18 crore<\/td>\n<\/tr>\n<tr>\n<td>Total Comprehensive Income<\/td>\n<td>Rs 28.88 crore<\/td>\n<td>Up 141.67% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The Venus Remedies share price rally is driven by profit growth of 139.27 percent that significantly outpaced the already strong 30.38 percent revenue growth, indicating meaningful margin expansion within the pharmaceutical manufacturing and export business during the quarter.<\/p>\n<p>The scale of the profit surge, more than doubling year on year, suggests better cost absorption kicking in as manufacturing capacity utilisation improves alongside a favourable product mix shift toward higher margin injectable and specialty formulations.<\/p>\n<p>While profit surged sequentially it remains below the Rs 47.49 crore reported in Q4 FY26, a reminder that pharmaceutical export businesses can see meaningful quarter to quarter variability tied to shipment timing and regulatory approval cycles, a factor investors in the Venus Remedies share price should keep in mind.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Consult a SEBI Registered Investment Advisor on Univest<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Venus_Remedies_Share_Price_Is_Reacting\"><\/span><strong>Why Venus Remedies Share Price Is Reacting<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Venus Remedies share price is reacting strongly because sustained expansion across pharmaceutical manufacturing and export operations, evidenced by 30 percent plus revenue growth, combined with profit more than doubling, signals the company&#8217;s investments in capacity and specialty formulations are beginning to pay off meaningfully.<\/p>\n<p>Injectable and critical care formulations typically command better margins and face less commoditised pricing pressure than standard oral generics, and continued growth in this segment appears to be a key driver behind the margin expansion this quarter.<\/p>\n<p>Export market diversification across multiple geographies reduces Venus Remedies&#8217;s dependence on any single regulatory or pricing environment, a structural positive that likely contributed to investor enthusiasm behind the Venus Remedies share price move.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Outlook_for_Venus_Remedies_Share_Price\"><\/span><strong>Outlook for Venus Remedies Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors tracking the Venus Remedies share price should watch for consistency in coming quarters, given the sequential decline from Q4 FY26 levels, to assess whether Q1 FY27&#8217;s strong YoY growth represents a sustainable new baseline or was aided by favourable shipment timing.<\/p>\n<p>Continued capacity expansion and new regulatory approvals in key export markets would support the medium term growth case, particularly for the higher margin injectable and specialty formulation segments the company has been prioritising.<\/p>\n<p>Raw material and active pharmaceutical ingredient cost trends will remain a variable to watch, since these directly affect margins in the specialty and generic injectable segments that are central to the Venus Remedies share price growth story.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Venus Remedies share price live and get instant Q1 result alerts.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Venus Remedies delivered an exceptional Q1 FY27, with consolidated profit surging 139.27 percent to Rs 22.97 crore on 30.38 percent revenue growth, lifting the Venus Remedies share price nearly 5 percent on 21 July 2026. Sustained expansion in injectable and export focused formulations appears to be driving genuine margin improvement, though sequential trends warrant monitoring for consistency. Consult a SEBI registered adviser before acting on the Venus Remedies share price.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Venus_Remedies_Q1_FY27_Results\"><\/span><strong>FAQs on Venus Remedies Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Venus_Remedies_share_price_rise_on_21_July_2026\"><\/span><strong>Why did Venus Remedies share price rise on 21 July 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Venus Remedies share price rose nearly 5 percent after the company reported Q1 FY27 consolidated net profit of Rs 22.97 crore, up 139.27 percent year on year, on revenue growth of 30.38 percent to Rs 178.86 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Venus_Remediess_revenue_growth_in_Q1_FY27\"><\/span><strong>What was Venus Remedies&#8217;s revenue growth in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Venus Remedies reported consolidated revenue from operations of Rs 178.86 crore in Q1 FY27, up 30.38 percent from Rs 137.18 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_products_does_Venus_Remedies_focus_on\"><\/span><strong>What products does Venus Remedies focus on?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Venus Remedies focuses on injectable formulations, oncology, and critical care pharmaceutical products, with a presence in both the Indian domestic market and international export markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_profit_grow_faster_than_revenue_in_Q1_FY27\"><\/span><strong>Why did profit grow faster than revenue in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Profit growth of 139.27 percent outpaced the 30.38 percent revenue growth, indicating margin expansion likely driven by a favourable shift toward higher margin injectable and specialty formulations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Venus_Remedies_profit_growth_sustainable_quarter_to_quarter\"><\/span><strong>Is Venus Remedies&#8217; profit growth sustainable quarter to quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Q1 FY27 profit was below the Rs 47.49 crore reported in Q4 FY26, showing sequential variability tied to shipment timing and regulatory approval cycles common in pharmaceutical export businesses.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Venus_Remedies_share_price_a_buy_after_the_Q1_results\"><\/span><strong>Is Venus Remedies share price a buy after the Q1 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not constitute investment advice. While growth was exceptional, investors should assess sequential consistency and consult a SEBI registered adviser before acting on the Venus Remedies share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Venus_Remedies_share_price_live\"><\/span><strong>Where can I track Venus Remedies share price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track the Venus Remedies share price live on the Univest app and website, along with quarterly result alerts and research on pharmaceutical and healthcare stocks.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why did Venus Remedies share price rise on 21 July 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Venus Remedies share price rose nearly 5 percent after the company reported Q1 FY27 consolidated net profit of Rs 22.97 crore, up 139.27 percent year on year, on revenue growth of 30.38 percent to Rs 178.86 crore.\"}},{\"@type\":\"Question\",\"name\":\"What was Venus Remedies's revenue growth in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Venus Remedies reported consolidated revenue from operations of Rs 178.86 crore in Q1 FY27, up 30.38 percent from Rs 137.18 crore in Q1 FY26.\"}},{\"@type\":\"Question\",\"name\":\"What products does Venus Remedies focus on?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Venus Remedies focuses on injectable formulations, oncology, and critical care pharmaceutical products, with a presence in both the Indian domestic market and international export markets.\"}},{\"@type\":\"Question\",\"name\":\"Why did profit grow faster than revenue in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Profit growth of 139.27 percent outpaced the 30.38 percent revenue growth, indicating margin expansion likely driven by a favourable shift toward higher margin injectable and specialty formulations.\"}},{\"@type\":\"Question\",\"name\":\"Is Venus Remedies' profit growth sustainable quarter to quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Q1 FY27 profit was below the Rs 47.49 crore reported in Q4 FY26, showing sequential variability tied to shipment timing and regulatory approval cycles common in pharmaceutical export businesses.\"}},{\"@type\":\"Question\",\"name\":\"Is Venus Remedies share price a buy after the Q1 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This article does not constitute investment advice. While growth was exceptional, investors should assess sequential consistency and consult a SEBI registered adviser before acting on the Venus Remedies share price.\"}},{\"@type\":\"Question\",\"name\":\"Where can I track Venus Remedies share price live?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can track the Venus Remedies share price live on the Univest app and website, along with quarterly result alerts and research on pharmaceutical and healthcare stocks.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Venus Remedies share price gained nearly 5% after Q1 FY27 consolidated net profit surged 139.27% YoY to Rs 22.97 crore on 30.38% revenue growth this quarter.<\/p>\n","protected":false},"author":35,"featured_media":160989,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[5130],"class_list":["post-160924","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-q1-fy27"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1784611750:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Venus Remedies Share Price Gains 5% on 139% Profit Surge"],"rank_math_description":["Venus Remedies share price gained nearly 5% after Q1 FY27 consolidated net profit surged 139.27% YoY to Rs 22.97 crore on 30.38% revenue growth this quarter."],"rank_math_focus_keyword":["Venus Remedies share price"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["160989"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["28506"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Venus-Remedies-Share-Price-Gains-Nearly-5.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/160924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=160924"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/160924\/revisions"}],"predecessor-version":[{"id":160992,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/160924\/revisions\/160992"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/160989"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=160924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=160924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=160924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}